1431326-50-9 Usage
Chemical structure
A complex molecular structure consisting of a cyclohexyl group, an ethyl group, a propan-2-yl group, and a benzoate group.
Application
Commonly used as a fragrance ingredient in various consumer products such as perfumes, lotions, and cosmetics.
Flavoring agent
Utilized in the manufacturing of flavored products and as a flavoring agent in food and beverages.
Stabilizer and fixative
Sometimes used as a stabilizer and fixative in the production of scented items.
Safety and regulatory considerations
Important for manufacturers and consumers to be aware of due to its use in everyday products.
Regulatory status
Depending on the specific application and concentration, it may be subject to different regulations and safety assessments.
Toxicological profile
The compound's toxicity and potential health effects should be evaluated to ensure safe use in consumer products.
Environmental impact
Consideration should be given to the potential environmental impact of the compound, particularly in terms of biodegradability and aquatic toxicity.
Manufacturing process
The synthesis of 1-(cyclohexyl(ethyl)amino)propan-2-yl benzoate may involve multiple steps and the use of various reagents and catalysts.
Purity and quality control
Ensuring the purity and quality of the compound is crucial for its performance and safety in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1431326-50-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,1,3,2 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1431326-50:
(9*1)+(8*4)+(7*3)+(6*1)+(5*3)+(4*2)+(3*6)+(2*5)+(1*0)=119
119 % 10 = 9
So 1431326-50-9 is a valid CAS Registry Number.
1431326-50-9Relevant articles and documents
Cyclohexylamines
-
Paragraph 0228, (2013/05/08)
The present application provides novel compounds and methods for preparing and using these compounds. These compounds are useful in treating pain, itch, overactive bladder and/or interstitial cystitis in patients by administering one or more of the compounds to a patient. The methods include administering a compound of formula (I) and a TRPV1 receptor activator. In one embodiment, the TRPV1 receptor activator is lidocaine.
